SLC6A4 and major depressive disorder: In contrast with the other two groups, which were treated with a medication which had no affinity for SERT (e.g., quetiapine) [51], the MDD group was primarily treated with antidepressants (e.g., SSRIs and venlafaxine) known to inhibit the SERT.